CSafe Global Expands in Korea with New Director of Sales

Dayton, OH Sep 28, 2015 – CSafe Global is pleased to announce Kevin Lee as the Director of Strategic Life Science Sales in Korea. Kevin will be responsible for growing the Korean market with CSafe’s comprehensive suite of active and passive cold chain protection solutions.
In this new role, Kevin will be reporting to Nadine Siqueland, Vice-President of Global Sales at CSafe. “Korea is of considerable strategic importance to CSafe. We’ve seen strong sales growth in Korea and in the Asia Pacific region overall,” says Nadine. “Kevin’s record of achievement developing the Korean biopharmaceutical market will be instrumental in helping us achieve our ambitious growth plans in this region. We are honored to have him join the global team.”
Kevin Lee is a highly experienced and successful sales leader with an exemplary twenty year track record in the Korean healthcare industry. He was educated at Pukyong National University in Business Administration. Before joining CSafe, Kevin worked in Korean sales leadership positions with the medical imaging specialist, Guerbet, and the pharmaceutical companies Schering-Plough (now Merck), Novo Nordisk and Daewoong Pharmaceutical.

Webinar: Avoiding the ICD-10 Fallout

Plano, TX and Pleasanton, CA Sep 23, 2015
Webinar: Avoiding the ICD-10 Fallout
Time: Wednesday, September 23rd @ 11 a.m. PST | 2 p.m. EST
Panelist: Derek Morkel, CEO of GAFFEY Healthcare
If you’re a healthcare finance or financial operations professional, you already understand the importance of revenue and maintaining a steady cash-flow for your organization – both of which will be put to the test upon the ICD-10 go-live.
In our next webinar, we review how our cloud-based automated claim statusing platform, AutoStatus, can quickly be implemented before the deadline and used to not only boost collector productivity but also as an ICD-10 mitigation strategy by:
• Detecting denials 14 – 21 days earlier
• ​Closely monitoring and reporting on collector efficiency
• Leveraging more detailed claim data than contained in a 277
• Eliminating the time-intensive task of checking claim statuses by phone or payer website, allowing collectors to focus on revenue generation

Altaris Capital Partners, LLC is pleased to announce that Healthcare Staffing Services (HSS) has been sold to Thomas H. Lee Partners.

New York, NY Sep 23, 2015 – Altaris Capital Partners, LLC is pleased to announce that Healthcare Staffing Services (HSS) has been sold to Thomas H. Lee Partners.
Founded in 1989 and acquired by Altaris in 2014, HSS is a highly differentiated provider of specialized travel nurse staffing solutions addressing hospitals’ most urgent and crucial temporary labor needs. The company’s ability to deliver the right nurse, at the right time, for the right length of time is supported by its focus on hospital efficiency and unique access to highly specialized nurses. HSS is headquartered in Greenwood Village, Colorado.
HSS and Altaris Capital Partners were advised on this transaction by Harris Williams & Co. and Schiff Hardin LLP.

NeuroVascular Quality Initiative® expands with new Cerebral Aneurysm and Cerebral AVMs modules

Chicago, IL and West Lebanon, NH Sep 16, 2015 – The Society of NeuroInterventional Surgery® (SNIS) and M2S®, a leading clinical registry provider, are pleased to announce the launch of the new Cerebral Aneurysm module for the NeuroVascular Quality Initiative (NVQI®), and the planned launch for the Cerebral Arteriovenous Malformations (AVMs) module in early October. The development of these web-based quality modules significantly broadens the scope of NVQI, and, together with the existing Acute Ischemic Stroke module, will provide new insights into outcomes and the efficacy of different NeuroInterventional therapies. The NVQI is the first clinical registry to focus exclusively on all aspects of neurovascular care.
The NVQI has already enrolled several facilities across five states and captured over 120 procedures. Additional contracts are in process for all three modules. Some of the current participating centers include the Cleveland Clinic, Erlanger Medical Center, Cadence Health Central DuPage Hospital, Novant-Forsyth Medical Center and Baylor University Medical Center at Dallas. Future NVQI modules are planned for 2016.
“To drive the quality improvements essential for our profession and for our patients, we need detailed outcomes data that only a registry designed for NeuroInterventional procedures can provide for us. The NVQI will be instrumental in building greater understanding of different patient populations and best practices as we start to tap into this valuable data source,” said Charles J. Prestigiacomo, MD, Medical Director of the SNIS Patient Safety Organization.
The NVQI has been designed to track key outcomes to demonstrate areas for clinical improvement. NVQI centers can compare processes, complication rates, and length of stay as well as medical device effectiveness. Specifically, NVQI is designed to support individual neurointerventionalists and hospitals by driving better understanding of outcomes and developing best practice in neurovascular surgery.
M2S has been working with the SNIS as their registry technology partner, and hosts the NVQI. All data are securely stored within the M2S PATHWAYS quality improvement data platform. All three NVQI modules track and measure individual procedures, as well as benchmark variation among different physicians and different centers and provide drill-down capabilities.
Betti Kerrigan, VP of Sales and Marketing for M2S, adds, “Use of M2S PATHWAYS will allow NVQI members to collect and analyze procedure data in greater detail, in real time. Together, PATHWAYS and NVQI can help hospitals and clinicians track neurovascular outcomes so they can drive quality and reduce costs.”

International Medical Group, Inc. Enters into Acquisition Agreement with ABRY Partners

Indianapolis, IN Sep 10, 2015 – International Medical Group®, Inc. (IMG®), a leader in the global insurance and assistance services market, has signed a definitive agreement to be acquired by ABRY Partners (ABRY), a leading private equity firm headquartered in Boston, Massachusetts.
“ABRY is a natural fit for ownership as IMG continues to grow,” said IMG President and CEO Brian Barwick. “With decades of experience investing in high-quality companies, ABRY will complement IMG’s growth by providing capital to further expand our global presence.”
IMG’s operations will not be impacted by the ownership change, Barwick said, adding, “It will be business as usual for our employees, producers and clients.”
Founded in 1989 as a managing general underwriter, IMG has become one of the leading international insurance providers in the world, serving members in more than 200 countries.
“Over the years, IMG has developed a reputation for excellence in the global insurance and assistance services markets,” said ABRY Partner Brent Stone. “We are excited to welcome such a well-established company to our portfolio and look forward to working with the IMG team.”
IMG’s executive management team, Board of Directors and current private equity partners — Altaris Capital Partners and Galen Partners — approved the agreement.
Executive Vice President and Chief Operating Officer Todd Hancock said, “ABRY shares our vision, energy and commitment to being there to protect and enhance the health and well-being of our constituents. We look forward to working with ABRY, and we are grateful to Altaris and Galen Partners for their support since August 2012.”

Austin Urologist Discusses Cryotherapy and Prostate Cancer Awareness Month with KTBC-TV

Indianapolis, IN Sep 8, 2015 – September is Prostate Cancer Awareness month, a time when the disease is brought into focus.
Dr. Eric Giesler, a urologist in Austin, Texas, talked about cryotherapy for recurrent prostate cancer with local Fox affiliate, KTBC.
Dr. Giesler’s patient and local pastor, Rick Cundieff, shared his prostate cancer journey and his positive experience with cryotherapy. Cundieff had the treatment twice — the first time in 2005, and then again this year when the cancer struck again.
Both Cundieff and Dr. Giesler urged men to start the conversation about prostate cancer, the PSA screening test, and treatment options, should a problem arise.
To watch the entire story, click below.
http://www.fox7austin.com/good-day/16984932-story

Expanded One-Way Lease Options Available

Dayton, OH Sep 2, 2015 – CSafe Global is pleased to announce a significant expansion of its available one-way trip lease options. CSafe Lessees can now return CSafe RKNs at no fee to more than half of the service centers in the CSafe network. In addition, new one-way options allow Lessees to end their lease in an additional 20 out-of-network CSafe locations with CSafe handling the container return transportation for a small additional fee.
“Post-lease container logistics have just gotten a lot easier,” remarked Mark Mohr, CSafe’s Director of Partner Management and Customer Support. “Our new one-way lease options provide for greatly enhanced container return choices and offers potential significant reductions in return logistics costs for customers choosing CSafe containers.”

Expanded One-Way Lease Options Available

Dayton, OH Sep 02, 2015 – CSafe Global is pleased to announce a significant expansion of its available one-way trip lease options. CSafe Lessees can now return CSafe RKNs at no fee to more than half of the service centers in the CSafe network. In addition, new one-way options allow Lessees to end their lease in an additional 20 out-of-network CSafe locations with CSafe handling the container return transportation for a small additional fee.
“Post-lease container logistics have just gotten a lot easier,” remarked Mark Mohr, CSafe’s Director of Partner Management and Customer Support. “Our new one-way lease options provide for greatly enhanced container return choices and offers potential significant reductions in return logistics costs for customers choosing CSafe containers.”
For additional details contact your local CSafe Global representative or email Leasing@CSafeGlobal.com.